Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB...
Gespeichert in:
Veröffentlicht in: | American journal of respiratory and critical care medicine 1998, Vol.157 (1), p.199-203 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 203 |
---|---|
container_issue | 1 |
container_start_page | 199 |
container_title | American journal of respiratory and critical care medicine |
container_volume | 157 |
creator | BJORAKER, J. A RYU, J. H EDWIN, M. K MYERS, J. L TAZELAAR, H. D SCHROEDER, D. R OFFORD, K. P |
description | Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p < 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF. |
doi_str_mv | 10.1164/ajrccm.157.1.9704130 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79671248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79671248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMoc07_gUIvxLvOnCZp2ksZfsFAQQXvQpomW0bb1KS98N-bubKr8_G-5-XwIHQNeAmQ03u580q1S2B8CcuSYwoEn6A5MMJSGufT2GNOUkrL73N0EcIOY8gKwDM0KyllBOM5-nj3btO5MFiVBLvprLFKdkonziRbGwbXy2HrGrfZ62MV9BAS2yW2tv9K3PZj07pO-t_E2Mq7YMMlOjOyCfpqqgv09fT4uXpJ12_Pr6uHdapIyYdU1nlpMHBFWGU4KQ3JFFcaCllxWuZFDaQGyYpaVwVUNeXAM2A1MaxiHAOQBbo75Pbe_Yw6DKK1QemmkZ12YxC8zDlktIhGejCq-F_w2oje2za-LACLPUtxYCkiSwFiYhnPbqb8sWp1fTya4EX9dtJlULIxPoKz4WjLYnJBKPkDL2t_kg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79671248</pqid></control><display><type>article</type><title>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>American Thoracic Society (ATS) Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>BJORAKER, J. A ; RYU, J. H ; EDWIN, M. K ; MYERS, J. L ; TAZELAAR, H. D ; SCHROEDER, D. R ; OFFORD, K. P</creator><creatorcontrib>BJORAKER, J. A ; RYU, J. H ; EDWIN, M. K ; MYERS, J. L ; TAZELAAR, H. D ; SCHROEDER, D. R ; OFFORD, K. P</creatorcontrib><description>Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p < 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/ajrccm.157.1.9704130</identifier><identifier>PMID: 9445300</identifier><language>eng</language><publisher>New York, NY: American Lung Association</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anti-Inflammatory Agents - therapeutic use ; Biological and medical sciences ; Biopsy ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Predictive Value of Tests ; Prednisone - therapeutic use ; Prognosis ; Proportional Hazards Models ; Pulmonary Fibrosis - classification ; Pulmonary Fibrosis - drug therapy ; Pulmonary Fibrosis - mortality ; Pulmonary Fibrosis - pathology ; Respiratory system : syndromes and miscellaneous diseases ; Retrospective Studies ; Survival Analysis</subject><ispartof>American journal of respiratory and critical care medicine, 1998, Vol.157 (1), p.199-203</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</citedby><cites>FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,4025,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2116834$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9445300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BJORAKER, J. A</creatorcontrib><creatorcontrib>RYU, J. H</creatorcontrib><creatorcontrib>EDWIN, M. K</creatorcontrib><creatorcontrib>MYERS, J. L</creatorcontrib><creatorcontrib>TAZELAAR, H. D</creatorcontrib><creatorcontrib>SCHROEDER, D. R</creatorcontrib><creatorcontrib>OFFORD, K. P</creatorcontrib><title>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p < 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Predictive Value of Tests</subject><subject>Prednisone - therapeutic use</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Pulmonary Fibrosis - classification</subject><subject>Pulmonary Fibrosis - drug therapy</subject><subject>Pulmonary Fibrosis - mortality</subject><subject>Pulmonary Fibrosis - pathology</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhoMoc07_gUIvxLvOnCZp2ksZfsFAQQXvQpomW0bb1KS98N-bubKr8_G-5-XwIHQNeAmQ03u580q1S2B8CcuSYwoEn6A5MMJSGufT2GNOUkrL73N0EcIOY8gKwDM0KyllBOM5-nj3btO5MFiVBLvprLFKdkonziRbGwbXy2HrGrfZ62MV9BAS2yW2tv9K3PZj07pO-t_E2Mq7YMMlOjOyCfpqqgv09fT4uXpJ12_Pr6uHdapIyYdU1nlpMHBFWGU4KQ3JFFcaCllxWuZFDaQGyYpaVwVUNeXAM2A1MaxiHAOQBbo75Pbe_Yw6DKK1QemmkZ12YxC8zDlktIhGejCq-F_w2oje2za-LACLPUtxYCkiSwFiYhnPbqb8sWp1fTya4EX9dtJlULIxPoKz4WjLYnJBKPkDL2t_kg</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>BJORAKER, J. A</creator><creator>RYU, J. H</creator><creator>EDWIN, M. K</creator><creator>MYERS, J. L</creator><creator>TAZELAAR, H. D</creator><creator>SCHROEDER, D. R</creator><creator>OFFORD, K. P</creator><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</title><author>BJORAKER, J. A ; RYU, J. H ; EDWIN, M. K ; MYERS, J. L ; TAZELAAR, H. D ; SCHROEDER, D. R ; OFFORD, K. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Predictive Value of Tests</topic><topic>Prednisone - therapeutic use</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Pulmonary Fibrosis - classification</topic><topic>Pulmonary Fibrosis - drug therapy</topic><topic>Pulmonary Fibrosis - mortality</topic><topic>Pulmonary Fibrosis - pathology</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BJORAKER, J. A</creatorcontrib><creatorcontrib>RYU, J. H</creatorcontrib><creatorcontrib>EDWIN, M. K</creatorcontrib><creatorcontrib>MYERS, J. L</creatorcontrib><creatorcontrib>TAZELAAR, H. D</creatorcontrib><creatorcontrib>SCHROEDER, D. R</creatorcontrib><creatorcontrib>OFFORD, K. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BJORAKER, J. A</au><au>RYU, J. H</au><au>EDWIN, M. K</au><au>MYERS, J. L</au><au>TAZELAAR, H. D</au><au>SCHROEDER, D. R</au><au>OFFORD, K. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>1998</date><risdate>1998</risdate><volume>157</volume><issue>1</issue><spage>199</spage><epage>203</epage><pages>199-203</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p < 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF.</abstract><cop>New York, NY</cop><pub>American Lung Association</pub><pmid>9445300</pmid><doi>10.1164/ajrccm.157.1.9704130</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-449X |
ispartof | American journal of respiratory and critical care medicine, 1998, Vol.157 (1), p.199-203 |
issn | 1073-449X 1535-4970 |
language | eng |
recordid | cdi_proquest_miscellaneous_79671248 |
source | MEDLINE; Journals@Ovid Complete; American Thoracic Society (ATS) Journals Online; EZB-FREE-00999 freely available EZB journals |
subjects | Adult Aged Aged, 80 and over Anti-Inflammatory Agents - therapeutic use Biological and medical sciences Biopsy Female Humans Male Medical sciences Middle Aged Pneumology Predictive Value of Tests Prednisone - therapeutic use Prognosis Proportional Hazards Models Pulmonary Fibrosis - classification Pulmonary Fibrosis - drug therapy Pulmonary Fibrosis - mortality Pulmonary Fibrosis - pathology Respiratory system : syndromes and miscellaneous diseases Retrospective Studies Survival Analysis |
title | Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T18%3A06%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20significance%20of%20histopathologic%20subsets%20in%20idiopathic%20pulmonary%20fibrosis&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=BJORAKER,%20J.%20A&rft.date=1998&rft.volume=157&rft.issue=1&rft.spage=199&rft.epage=203&rft.pages=199-203&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/ajrccm.157.1.9704130&rft_dat=%3Cproquest_cross%3E79671248%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79671248&rft_id=info:pmid/9445300&rfr_iscdi=true |